Who Paid My Doc
JenaValve Pericardial TAVR System
Device Cardiology
General payments
$4,195,864
Research payments
$232,079
Through program year 2023, $4,195,864 in general payments and $232,079 in research payments were reported against JenaValve Pericardial TAVR System (Cardiology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $899,216 | 105 |
| 2023 | Research | $80,555 | 1 |
| 2022 | General | $1,440,896 | 104 |
| 2022 | Research | $71,107 | 1 |
| 2021 | General | $705,281 | 76 |
| 2021 | Research | $45,418 | 1 |
| 2020 | General | $449,282 | 42 |
| 2020 | Research | $34,999 | 1 |
| 2019 | General | $701,189 | 47 |
Breakdown
The top 5 of 79 recipients; each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 26 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
374 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.